@geraldineram
Corporate or institutional collaborations reduce execution risk but introduce regulatory obligations. Working with large banks or brands enhances credibility, potential adoption, and funding access. However, compliance costs, reporting requirements, and oversight can slow innovation. Trade-offs should be reflected in valuations by adjusting expected net cash flows, discount rates, or operational risk premiums. Scenario modeling can simulate the impact of additional regulatory scrutiny on profitability and execution speed. In investment models, strategic partnerships should be treated as both optionality for upside and a source of predictable obligations, balancing reduced risk with potential cost drag.